Encapsulated Bacteria of Concern After Splenectomy
The three main encapsulated bacteria that pose significant infection risk after splenectomy are Streptococcus pneumoniae (most common, causing 50% of cases), Haemophilus influenzae type B, and Neisseria meningitidis. 1, 2
Overwhelming Post-Splenectomy Infection (OPSI)
OPSI is a life-threatening medical emergency characterized by:
- Fulminant sepsis, meningitis, or pneumonia primarily caused by encapsulated bacteria 1
- Mortality rate of 30-70%, with most deaths occurring within the first 24 hours 1
- Incidence of 0.5-2% in splenectomized patients 1
- Highest risk in the first year after splenectomy, but remains elevated for more than 10 years and likely for life 1, 2
Risk Factors for OPSI
- Children under 5 years have greater overall risk with increased mortality compared to adults 1, 2
- Neonates have a risk exceeding 30% 1
- Hyposplenic patients (those with partially functioning spleens after embolization) should also be considered at risk 1
Specific Pathogens
Streptococcus pneumoniae:
Haemophilus influenzae type B:
Neisseria meningitidis:
Other pathogens:
Prevention Strategies
Vaccination
- Immunization against encapsulated bacteria is essential 1, 2
- Optimal timing:
- Annual influenza vaccination is recommended for patients over 6 months of age 1, 2
Antibiotic Prophylaxis
- Antibiotic therapy should be promptly initiated for any sudden onset of unexplained fever, malaise, or chills 1
- Patients should have a home supply of antibiotics for emergency use 1, 2
- Lifelong prophylactic antibiotics may be considered, especially in the first two years after splenectomy 2
Patient Education
- Patients should be educated about their lifelong increased risk of infection 2
- Patients should carry identification indicating their asplenic status 1, 2
- Primary care providers should be informed of the patient's asplenic status 1, 2
Important Caveats
- Current vaccines do not provide complete coverage against all serotypes of encapsulated bacteria 1, 2
- Despite vaccination, breakthrough infections can occur with serotypes not covered by vaccines 5
- Vaccination coverage rates remain suboptimal in many healthcare settings 6
- OPSI can present with non-specific symptoms initially, leading to delayed diagnosis and treatment 5